A reemerging and an underreported infectious disease

Saudi Medical Journal

Volumn 35, Issue 10, 2014, Pages 1181-1187

  Syed, Muhammad A ^a   Bana, Noureen F ^b  

^a KPK   (Pakistan)

^b Department of Nursing Triple A Living Communities Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADAPTATION; ARTICLE; BORDETELLA PERTUSSIS; DISEASE RE-EMERGENCE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DNA POLYMORPHISM; GENE FREQUENCY; IMMUNITY; PATHOGENESIS; PERTUSSIS; VACCINATION; ADOLESCENT; ADULT; CHILD; COMMUNICABLE DISEASE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EPIDEMIC; HEALTH; HUMAN; IMMUNIZATION; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISEASE OUTBREAKS; GLOBAL HEALTH; HUMANS; IMMUNIZATION, SECONDARY; INFANT; PERTUSSIS VACCINE; WHOOPING COUGH; YOUNG ADULT;

EID: 84908012906     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Mattoo S, Cherry JD, Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005; 18: 326-382.
2. Bokhari H, Said F, Syed MA, Mughal A, Kazi YF, Heuvelman K, et al. Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009. Scand J Infect Dis 2011; 43: 818-820.
3. Syed MA, Ahmed W, Naeem A, Bokhari H. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children. J Coll Physicians Surg Pak 2012; 22: 677-678.
4. Syed MA, Said F, Bukhari H. Seroepidemiology of B. pertussis infections in the twin cities of Pakistan. North Am J Med Sci 2009; 1: 353-355.
5. Chiappini E, Stival A, Galli L, de Martino M. Pertussis reemergence in the post-vaccination era. BMC Infect Dis 2013; 26: 151.
6. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009; 15: 1206-1213.
7. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccinedriven evolution. Infect Immun 1998; 66: 670-675.
8. Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 2000; 19: 174-181.
9. van Loo IH, van der Heide HG, Nagelkerke NJ, Verhoef J, Mooi FR. Temporal trends in the population structure of Bordetellapertussis during 1947-96 in a highly vaccinated population. J Infect Dis 1999; 179: 915-23.
10. Cherry JD. Pertussis challenges today and for the future. PloS Patholog 2013; 9: 7.
11. Poolman JT, Hallander H, Halperin SA. Pertussis vaccines: Where to now? Expert Rev Vaccines 2011; 10: 1497-1500.
12. Baugh V, McCarthy N. Outbreak of Bordetella pertussis among oncology nurse specialists. Occupat Med 2010; 60: 401-405.
13. Syed MA. Adolescent and adult pertussis-lack of data from South Asian and African regions. Pak J Med Sci 2012; 28: 1.
14. de Melker HE, Conyn-van Spaendonck MA, Rümke HC, van Wijngaarden JK, Mooi FR, Schellekens JF. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole cell vaccine. Emerg Infect Dis 1997; 3: 175-178.
15. World Health Organization: Pertussis. [Updated 2011 June 21; Accessed 2014 May 16]. Available from URL: http://www.who. int/immunization/topics/pertussis/en/
16. Smith S, Tilton RC. Acute Bordetella pertussis infection in an adult. J Clin Microbiol 1996; 34: 429-430.
17. Bassinet L, Matrat M, Njamkepo E, Aberrane S, Housset B, Guiso N. Nosocomial pertussis outbreak among adult patients and health care workers. Infect Control Hosp Epidemiol 2004; 25: 995-997.
18. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Kurose K, Oka, M. Outbreak of pertussis in a university laboratory. Intern Med 2011; 50: 879-885.
19. Waters V, Jamieson F, Richardson SE, Finkelstein M, Wormsbecker A, Halperin SA. Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool aged children. Pedriatr Infect Dis J 2009; 28: 582-587.
20. Winter K, Harriman K, Zipprich J, Schechter R, Talarico J, Watt J, et al. California pertussis epidemic 2010. J Pediatr 2012; 61: 1091-1096.
21. Gabutti G, Rota MC. Pertussis: A review of disease epidemiology worldwide and in Italy. Int J Environ Res Public Health 2012; 9: 4626-4638.
22. Grilc E, Pirnat N. Pertussis outbreak in recently vaccinated children in a kindergarten in Ljubljana during a resurgence in pertussis incidence. Euro Surveill 2005; 10: E050818.4.
23. Sin MA, Zenke R, Rönckendorf R, Littmann M, Jorgensen P, Hellenbrand W. Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany demonstrating the role of waning immunity. Pediatr Infect Dis J 2009; 28: 242-244.
24. Torm S, Meriste S, Tamm E, Alusalu S, Järviste A, Lang K. Pertussis outbreak in a basic school in Estonia: description, contributing factors and vaccine effectiveness. Scand J Infect Dis 2005; 37: 664-668.
25. Berger F, Njamkepo E, Minaberry S, Mayet A, Haus-Cheymol R, Verret C, et al. Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy. Vaccine 2010; 28: 5147-52.
26. Dudman SG, Trøseid M, Jonassen TO, Steinbakk M. Whooping cough: An increasing problem in Norway. Tidsskr Nor Laegeforen. 2006; 126: 305-308.
27. Matter HC. Pertussis surveillance in Switzerland, 1992 to 1997 a large epidemic in 1994. What next? Euro Surveill 1999; 4: 51.
28. Campins M, Moreno-Pérez D, Gil-de Miguel A, González- Romo F, Moraga-Llop FA, Arístegui-Fernández J, et al. Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group. Enferm Infect Microbiol Clin 2013; 31: 240-253.
29. Hozbor D, Mooi F, Flores D, Weltman G, Bottero D, Fossati S. Pertussis epidemiology in Argentina: trends over 2004-2007. J Infect 2009; 59: 225-231.
30. Nitsch-Osuch A, Kuchar E, Modrzejewska G, Pirogowicz I, Zycinska K, Wardyn K. Epidemiology of pertussis in an urban region of Poland: time for a booster for adolescents and adults. Adv Exp Med Biol 2013; 755: 203-212.
31. Paradowska-Stankiewicz I, Rudowska J. Pertussis in Poland in 2011. Przegl Epidemiol 2013; 67: 199-201, 319-21.
32. Senanayake S. Pertussis in adults today. A disaese of adolescent and adults that can kill infants. Aust Fam Physician 2007; 36: 51-55.
33. Poynten M, McIntyre PB, Mooi FR, Heuvelman K, Gilbert G L. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiol Infect 2004; 132: 185-193.
34. Choi J. Australia’s experience of Bordetella pertussis and a proposed national preventive strategy into the future. Australian Medical Student Journal 2012; 3: 27-30.
35. Rothstein E, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005; 24: S44-S47.
36. Horby P, MacIntyre CR, McIntyre PB, Gilbert GL, Staff M, Hanlon M, et al. A boarding school outbreak of pertussis in in adolescents: value of laboratory diagnostic methods. Epidemiol Infect 2005; 133: 229-236.
37. Srugo I, Benilevi D, Madeb R, Shaprio S, Shohat T, Somekh E. Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerg Infect Dis 2000; 6: 526-529.
38. Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, Mayon-White R, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ 2006; 333: 174-177.
39. Wright SW. Pertussis infection in adults. South Med J 1998; 91: 701-708.
40. Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007; 26: 293-299.
41. Syed MA, Bokhari, SH. Adult and adolescent pertussis should not be underestimated! Pak J Med Sci 2010; 26: 244-245.
42. Hoey J. Epidemiology, diagnosis, treatment, and prevention of pertussis (whooping cough). Can Med Assoc J 2003; 188: 453-454.
43. Puig-Barberà J, Díez-Domingo J, Pastor-Villalba E, Garcia- Lomas J, Huertas-Zarco I, Pérez-Hoyos S. Pertussis in adults with persistent cough: a prospective follow up study in primary care. Procedia Vaccinol 2009; 1: 73-80.
44. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, Mazurova I, et al. Antigenic divergence between B. pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 2007; 14: 234-238.
45. van Loo IH, Heuvelman KJ, King AJ, Mooi FR. Multilocus sequence typing of B. pertussis based on surface protein genes. J Clin Microbiol 2002; 40: 1994-1901.
46. Yao SM, Lin YC, Chou CY, Chen YY, Hsiao MJ, Chen HY, et al. Antigenic divergence of B. pertussis isolates in Taiwan. J Clin Microbiol 2005; 43: 5457-5461.
47. Gzyl A, Augustynowicz E, Van Loo I, Sluzarczyk J. Temporal neucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 2001; 20: 299-303.
48. Litt DJ, Neal SE, Fry NK. Changes in genetic diversity of the B. pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of single dominant clonal type. J Clin Microbiol 2009; 47: 680-688.
49. Mooi FR. Bordetella pertussis and vaccination: the persistence of genetic monomorphic pathogen. Infect Genet Evol 2010; 10: 36-49.
50. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, Mazurova I, et al. Antigenic divergence between B. pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 2007; 14: 234-238.
51. Fingermann M, Fernandez J, Sisti F, Rodriguez ME, Gatti B, Bottero D, et al. Differences of circulating B. pertussis population in Argentina from the strain used in vaccine production. Vaccine 2006; 24: 3513-3521.
52. Mastrantonio P, Stefanelli P, Giuliano N, Rojas YH, Atti A CD, Anemona A, et al. Bordetella parapertussis infections in children: Epidemiology, clinical symptoms and molecular characteristics of isolates. J Clin Microbiol 1998; 36: 999-1002.
53. Poynten M, McIntyre PB, Mooi FR, Heuvelman K, Gilbert JL. Temporal trends in circulating B. pertussis strains in Australia. Epidemiol Infect 2004; 132: 185-193.
54. Mastrantonio P, Spigaglia P, van Oirschot H, van der Heide HG, Heuvelman K, Stefanelli P, et al. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 1999; 145: 2069-2075.
55. Borisova O, Kombarova SY, Zakharova NS, van Gent M, Aleshkin VA, Mazurova I, et al. Antigenic divergence between B. pertussis clinical isolates from Moscow, Russia, and vaccine strains. Clin Vaccine Immunol 2007; 14: 234-438.
56. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009; 15: 1206-1213.
57. Mooi FR, Van der Maas, de Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation-two sides of the same coin. Epidemiol Infect 2014; 142: 685-694.
58. Wood N, Mcintyre P. Pertussis: review of epidemiology, diagnosis, management and prevention. Pediatr Respir Rev 2008; 9: 201-12.
59. Wang CQ, Zhu QR. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China. Pediatr Infect Dis J 2011; 30: 593-596.
60. Xu Y, Wang L, Xu J, Wang X, Wei C, Luo P, et al. Seroprevalence of pertussis in China: Need to improve vaccination strategies. Human Vaccin Immunother 2014; 10: 192-198.
61. Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis 2012; 12: 138.
62. Esen B, Coplu N, Kurtoglu D, Gozalan A, Akin L. Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants. J Clin Lab Anal 2007; 21: 154-161.
63. Aksakal FN, Cöplü N, Ceyhan MN, Sönmez C, Ozkan S, Esen B, et al. High incidence of pertussis among schoolchildren with prolonged cough in Turkey. Tohoku J Exp Med 2007: 353-358.
64. Eslamifar A, Ramezani A, Banifazl, M, Khadem-Sadegh A, Aghakhani A. Iranian Journal of Pathology 2012; 7: 171-176.
65. Shapiro E D. Acellular vaccines and resurgence of pertussis. JAMA 2012; 308: 2149-2150.
66. Klein NP, Bartlett J, Fireman B, Rowhani-Rahbar A, Baxter R. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013; 131: e1716-e1722.
67. Liko J, Ribison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 2013; 368: 581-582.
68. Halperin SA, Serres GD. Has the change to acellular pertussis vaccine improved or worsened pertussis control? CMAJ 2006; 175: 1227-1228.
69. Mughal A, Kazi YF, Bukhari H., Ali M. Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan. Public Health 2012; 126: 518-522.
70. Bokhari H, Said F, Syed MA, Hussain A, Kazi YF, Kallonen T, et al. Molecular typing of Bordetella parapertussis isolates circulating in Pakistan. FEMS Immunol Med Microbiol 2011; 63: 373-380.
71. Bokhari H, Said F, Syed MA, Mughal A, Kazi YF, Heuvelman K, et al. Whooping cough in Pakistan: Bordetella pertussis vs. Bordetella parapertussis in 2005-2009. Scand J Infect Dis 2011; 43: 818-820.